Depenbusch Marion, von Eckardstein Sigrid, Simoni Manuela, Nieschlag Eberhard
Institute of Reproductive Medicine of the University, Domagkstr. 11, Munster D-48149, Germany.
Eur J Endocrinol. 2002 Nov;147(5):617-24. doi: 10.1530/eje.0.1470617.
It is generally accepted that both gonadotropins LH and FSH are necessary for initiation and maintenance of spermatogenesis. We investigated the relative importance of FSH for the maintenance of spermatogenesis in hypogonadotropic men.
13 patients with gonadotropin deficiency due to idiopathic hypogonadotropic hypogonadism (IHH), Kallmann syndrome or pituitary insufficiency were analyzed retrospectively. They had been treated with gonadotropin-releasing hormone (GnRH) (n=1) or human chorionic gonadotropin/human menopausal gonadotropin (hCG/hMG) (n=12) for induction of spermatogenesis. After successful induction of spermatogenesis they were treated with hCG alone for maintenance of secondary sex characteristics and in order to check whether sperm production could be maintained by hCG alone. Serum LH, FSH and testosterone levels, semen parameters and testicular Volume were determined every three to six Months.
After spermatogenesis had been successfully induced by treatment with GnRH or hCG/hMG, hCG treatment alone continued for 3-24 Months. After 12 Months under hCG alone, sperm counts decreased gradually but remained present in all patients except one who became azoospermic. Testicular Volume decreased only slightly and reached 87% of the Volume achieved with hCG/hMG. During treatment with hCG alone, FSH and LH levels were suppressed to below the detection limit of the assay.
Once spermatogenesis is induced in patients with secondary hypogonadism by GnRH or hCG/hMG treatment, it can be maintained in most of the patients qualitatively by hCG alone, in the absence of FSH, for extended periods. However, the decreasing sperm counts indicate that FSH is essential for maintenance of quantitatively normal spermatogenesis.
普遍认为促性腺激素LH和FSH对于精子发生的启动和维持均是必需的。我们研究了FSH在维持低促性腺激素男性精子发生中的相对重要性。
回顾性分析13例因特发性低促性腺激素性腺功能减退(IHH)、卡尔曼综合征或垂体功能不全导致促性腺激素缺乏的患者。他们曾接受促性腺激素释放激素(GnRH)(n = 1)或人绒毛膜促性腺激素/人绝经期促性腺激素(hCG/hMG)(n = 12)治疗以诱导精子发生。在成功诱导精子发生后,他们仅接受hCG治疗以维持第二性征,并检查仅用hCG是否能维持精子生成。每三到六个月测定血清LH、FSH和睾酮水平、精液参数及睾丸体积。
在用GnRH或hCG/hMG治疗成功诱导精子发生后,仅用hCG治疗持续3 - 24个月。仅用hCG治疗12个月后,精子计数逐渐下降,但除1例无精子症患者外,所有患者仍有精子。睾丸体积仅略有下降,降至hCG/hMG治疗时所达到体积的87%。在仅用hCG治疗期间,FSH和LH水平被抑制至检测限以下。
继发性性腺功能减退患者经GnRH或hCG/hMG治疗诱导精子发生后,在无FSH的情况下,大多数患者仅用hCG可长期维持精子发生的质量。然而,精子计数的下降表明FSH对于维持定量正常的精子发生至关重要。